Viral Load in Non-Surviving Liberian Ebola Virus Disease Patients Is Underestimated by Diagnostic qRT-PCR: A Retrospective Observational Study

2021 ◽  
Author(s):  
M. Jeremiah Matson ◽  
Emily Ricotta ◽  
Friederike Feldmann ◽  
Moses Massaquoi ◽  
Armand Sprecher ◽  
...  
2016 ◽  
Vol 42 ◽  
pp. 34-39 ◽  
Author(s):  
Jin Li ◽  
Hui-Juan Duan ◽  
Hao-Yang Chen ◽  
Ying-Jie Ji ◽  
Xin Zhang ◽  
...  

2018 ◽  
Vol 218 (4) ◽  
pp. 555-562 ◽  
Author(s):  
Jerry F Brown ◽  
John M Dye ◽  
Sam Tozay ◽  
Gertrude Jeh-Mulbah ◽  
David A Wohl ◽  
...  

Enzyme-linked immunosorbent and microneutralization assays of 180 Ebola convalescent plasma specimens were highly concordant and predictive for detection of antibody by 50% plaque reduction neutralization test. Viral load decreased following infusion of antibody-containing plasma in 2 Ebola virus disease patients.


2015 ◽  
Vol 15 (3) ◽  
pp. 320-326 ◽  
Author(s):  
Ousmane Faye ◽  
Pierre-Yves Boëlle ◽  
Emmanuel Heleze ◽  
Oumar Faye ◽  
Cheikh Loucoubar ◽  
...  

2015 ◽  
Vol 62 (1) ◽  
pp. 19-23 ◽  
Author(s):  
Jean Marie Cournac ◽  
Ludovic Karkowski ◽  
Julien Bordes ◽  
Marc Aletti ◽  
Sandrine Duron ◽  
...  

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Xiaofeng Dong ◽  
Jordana Munoz-Basagoiti ◽  
Natasha Y. Rickett ◽  
Georgios Pollakis ◽  
William A. Paxton ◽  
...  

Abstract Background Viral load is a major contributor to outcome in patients with Ebola virus disease (EVD), with high values leading to a fatal outcome. Evidence from the 2013–2016 Ebola virus (EBOV) outbreak indicated that different genotypes of the virus can have different phenotypes in patients. Additionally, due to the error-prone nature of viral RNA synthesis in an individual patient, the EBOV genome exists around a dominant viral genome sequence. The minor variants within a patient may contribute to the overall phenotype in terms of viral protein function. To investigate the effects of these minor variants, blood samples from patients with acute EVD were deeply sequenced. Results We examine the minor variant frequency between patients with acute EVD who survived infection with those who died. Non-synonymous differences in viral proteins were identified that have implications for viral protein function. The greatest frequency of substitution was identified at three codon sites in the L gene—which encodes the viral RNA-dependent RNA polymerase (RdRp). Recapitulating this in an assay for virus replication, these substitutions result in aberrant viral RNA synthesis and correlate with patient outcome. Conclusions Together, these findings support the notion that in patients who survived EVD, in some cases, the genetic variability of the virus resulted in deleterious mutations that affected viral protein function, leading to reduced viral load. Such mutations may also lead to persistent strains of the virus and be associated with recrudescent infections.


2015 ◽  
Vol 2 (4) ◽  
Author(s):  
Jeffrey K. Edwards ◽  
Christian Kleine ◽  
Vincent Munster ◽  
Ruggero Giuliani ◽  
Moses Massaquoi ◽  
...  

Abstract Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) is the most sensitive quantitative diagnostic assay for detection of Ebola virus in multiple body fluids. Despite the strengths of this assay, we present 2 cases of Ebola virus disease (EVD) and highlight the potential for false-negative results during the early and late stages of EVD. The first case emphasizes the low negative-predictive value of qRT-PCR during incubation and the early febrile stage of EVD, and the second case emphasizes the potential for false-negative results during recovery and late neurologic complications of EVD. Careful interpretation of test results are needed to guide difficult admission and discharge decisions in suspected or confirmed EVD.


Sign in / Sign up

Export Citation Format

Share Document